Comparable increases were noted for MS4A4A, MS4A4E, MS4A6A, MS4A7, and MS4A14 in FCD_2b patients, and for MS4A4A, MS4A7, and MS4A14 in TSC patients. Here, MS4A6A is linked to tuberous sclerosis.